Biotech Stocks in Focus (ACST,MLND, JNCE,RMTI,XXII,DVAX)

News Alert: Citius Pharmaceuticals Receives FDA Approval For LYMPHIR™ (Denileukin Diftitox-Cxdl) Immunotherapy For The Treatment Of Adults With Relapsed Or Refractory Cutaneous T-Cell Lymphoma. Click to Read More.

The market is looking to open up down over 400 points on the Dow Jones this morning due to the expanding of the coronavirus news this weekend. This week is likely to be a very volatile one due to the coronavirus and that a ton of large cap companies have earnings. Just to name a few: Apple, AMD, Tesla, Amazon, Microsoft, Facebook, and General Electric.

That means that the market is likely to make humongous swings. That could lead to gigantic returns on the options if you are on the right side.

Biotechs have been on fire! Short term 1-3 day swings is where the money has been at for the last few weeks, but given the situation in China and the “risk off” environment entering the markets as we get into earnings season – I think it’ll be time to be a bit patient now.

Catalyst Swing Names (1-4 week holds) that I am watching

Acasti Pharma (ACST)

Catalyst Dates: Phase 3 data due Mid-February (first trial failed)

Buy Zone: $.50 to $.60

Profit Zone: $.75 or higher

Stop Zone: $.51 or below

Millendo Therapeutics (MLND)


Catalyst Dates: Phase 2/3 data coming likely in March


Buy Zone: $7.50 to $8.10

Profit Zone: $9.00 or higher

Stop Zone: $7.10 or below

Jounce Therapeutics (JNCE)

Catalyst Dates: New Phase 1/2 cancer dated to be presented on February 6th

Buy Zone: $6.00 to $6.50

Profit Zone: $7.00 or higher

Stop Zone: $5.75 or below

Rockwell Medical (RMTI)

Catalyst Dates: FDA Approval date of March 28th

Buy Zone: $2.30 to $2.50

Profit Zone: $2.90 or higher

Stop Zone: $2.10 or below


22nd Century Group (XXII)

Catalyst Dates: Advisory Panel on February 14th

Buy Zone: $1.00 to $1.10

Profit Zone: $1.50 or higher

Stop Zone: $.90 or below

Dynavax (DVAX)

Catalyst Dates: Possible european CHMP decision coming in January 


Buy Zone: $5.50 to $5.80

Profit Zone: $6.00 or higher

Stop Zone: $5.45 or below

Lannett Company (LCI)


Catalyst Dates: Possible FDA approval coming Early 2020 


Buy Zone: Below $8 (wait)

Profit Zone: $9.00 or higher

Stop Zone: $7.25 or below